High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.5M
$1,465,122
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ANIP
S
ANI PHARMACEUTICALS INC
Davis Krista
• Officer • SVP, CHIEF HR OFFICER
10b5-1 Sell
2026-03-09
$377,099
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • SVP, CHIEF HR OFFICER
10b5-1 Sell
|
2026-03-09 | $377,099 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-03-09
$267,196
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-03-09 | $267,196 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Davis Krista
• Officer • SVP, CHIEF HR OFFICER
10b5-1 Sell
2026-03-06
$111,375
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • SVP, CHIEF HR OFFICER
10b5-1 Sell
|
2026-03-06 | $111,375 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-03-06
$157,421
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-03-06 | $157,421 | S | Form 4 |
| ANIP |
ANI PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-05 | $163,977 | M | Form 4 |
| ANIP |
ANI PHARMACEUTICALS INC
|
CFO
Discretionary Sell
|
2026-03-05 | $552,031x2 | S | Form 4 |